Vxrt nasdaq Find the latest Financials data for Vaxart, Inc Common Stock (VXRT) at Nasdaq. 40 and traded as low as $0. The virtual meeting will address all proposals from the proxy statement filed on April 10, 2025. At Stock Options Channel, our YieldBoost formula has looked up and down the VXRT 3 days ago · Which executives are buying and selling shares of Vaxart stock? View the latest VXRT insider trading activity at MarketBeat. (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing. The board has approved two key changes contingent on the passage of Proposal #2: limiting the reverse stock split ratio to no more than 1-for-20 and proposing to proportionally reduce the authorized number of common stock shares at a future special stockholder meeting. Latest stock price today and the US' most active stock market forums. 68M. , July 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. On top of that, the share price is up 19% in about a quarter. com. But unlike some other small-cap long-shots, like Ocugen (NASDAQ:OCGN), it has a lot more going for it. The board of Aug 2, 2023 · Fintel reports that on August 7, 2023, Cantor Fitzgerald maintained coverage of Vaxart (NASDAQ:VXRT) with a Overweight recommendation. , May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The meeting, which includes a critical reverse stock split proposal to maintain Nasdaq listing, was postponed to give shareholders more time to consider recent board changes, potential governance modifications, and upcoming company Jun 13, 2025 · SOUTH SAN FRANCISCO, Calif. 91%, respectively, for the quarter ended June 2025. stock information by Barron's. 34. 28%, respectively, for the quarter ended December 2024. Vaxart, Inc. Free forex prices, toplists, indices and lots more. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral 3 days ago · VXRT's current price target is $2. The company reported earnings of -$0. (VXRT) stock, with detailed revenue and earnings estimates. Jan 14, 2025 · (RTTNews) - Vaxart, Inc. View (VXRT) real-time stock price, chart, news, analysis, analyst reviews and more. (VXRT) stock. (VXRT), which gained more than 50% yesterday, is up over 6% at $12. 49 and traded as low as $0. (NASDAQ:VXRT - Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . There has been approximately $48,801,056 of trading volume. (NASDAQ:VXRT - Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . Aug 14, 2025 · Vaxart Inc (VXRT) reports a significant revenue increase but faces hurdles with trial suspensions and NASDAQ compliance issues. The stock's 50-day moving average is $0. 5 days ago · A high-level overview of Vaxart, Inc. Reported EPS is $-0. Mar 20, 2025 · VAXART ($VXRT) posted quarterly earnings results on Thursday, March 20th. 3627. This compares to loss of $0. The OTCQX Market provides companies with cost-effective access to U. Short interest Apr 24, 2020 · COVID-19 has boosted the fortunes of several previously unknown biotechs. (VXRT) including earnings per share, earnings forecasts at Nasdaq. 03. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral Stay up-to-date on Vaxart, Inc Common Stock (VXRT) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. This proposal is aimed at addressing the company's current non-compliance with Nasdaq’s minimum bid price requirement of $1. 05. The meeting, which includes a critical reverse stock split proposal to maintain Nasdaq listing, was postponed to give shareholders more time to consider recent board changes, potential governance modifications, and upcoming company Find the latest Insider Activity data for Vaxart, Inc Common Stock (VXRT) at Nasdaq. Aug 6, 2024 · Fintel reports that on August 15, 2024, Oppenheimer initiated coverage of Vaxart (NasdaqCM:VXRT) with a Outperform recommendation. Aug 8, 2025 · Vaxart (OTCQX: VXRT) CEO Steven Lo has issued a critical letter to stockholders urging them to vote in favor of a reverse stock split proposal by September 4, 2025. Sean Tucker, the company's Founder Jun 2, 2025 · Vaxart's annual meeting adjourned to June 13, 2025, with proxy support for Proposal #2 from leading advisory firms. (NASDAQ:VXRT) shareholders would be excited to see that the share price has had a great month, posting a 34% gain and recovering from prior weakness. Jul 8, 2025 · Is Vaxart (VXRT) completely delisted from Nasdaq? Vaxart's stock is currently suspended from Nasdaq pending a decision from the Nasdaq Hearings Panel, following the company's request for a hearing under Nasdaq Listing Rule 5800 Series. 07, expectations were $-0. May 29, 2025 · Dr. , Jan. Source: Photo courtesy of May 16, 2025 · Vaxart (VXRT) has announced important amendments to its proxy statement for the upcoming Annual Meeting. Oct 7, 2021 · Vaxart, Inc. For comments and feedback contact: editorial@rttnews. today answers additional frequently asked stockholder questions it has received from retail investors in advance of the Company’ s Annual Meeting of Stockholders scheduled to take Aug 17, 2024 · Find the latest institutional holdings data for Vaxart, Inc Common Stock (VXRT) including shareholders, ownership summaries, and holding activities at Nasdaq. 05 per share, beating estimates of -$0. Stockholders: We are writing to Discover real-time Vaxart, Inc Common Stock (VXRT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. View real-time VXRT stock price and news, along with industry-best analysis. (VXRT), analyze all the data with a huge range of indicators. 39. announced that Dr. Operator: Greetings, and 5 days ago · A high-level overview of Vaxart, Inc. Jul 14, 2020 · The phase I study is expected to begin by year-end 2020. 09 per share versus the Zacks Consensus Estimate of $0. The stock has a 200-day moving average of $0. 51 in after-hours, up 0. Get the most current trading insights on Vaxart, Inc Common Stock (VXRT) with Nasdaq. has urged its stockholders to vote in favor of Interactive Chart for Vaxart, Inc. 41 and traded as low as $0. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral Jan 14, 2025 · SOUTH SAN FRANCISCO, Calif. Following trading suspension due to non-compliance with Sep 8, 2021 · Vaxart (NASDAQ:VXRT) stock is a high-risk Covid-19 vaccine play. Aug 8, 2024 · VAXART, INC. (NASDAQ: VXRT) Q3 2025 Earnings Call Transcript November 13, 2025 Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its Oct 9, 2024 · Vaxart Inc (VXRT) reports significant revenue growth and secures substantial funding, while navigating regulatory challenges and advancing its vaccine programs. (NASDAQ:VXRT) has received a notice from Nasdaq stating that it no longer meets the minimum bid price requirement for continued listing on The Nasdaq Capital 3 days ago · View Vaxart (NASDAQ:VXRT) historical prices, past price performance, and an advanced VXRT stock chart at MarketBeat. com Business News Jun 10, 2025 · SOUTH SAN FRANCISCO, Calif. Operator: Greetings, and May 2, 2022 · (RTTNews) - The following are some of the stocks making big moves in Monday's pre-market trading (as of 07. The company has transitioned from its previous NASDAQ listing and commenced trading on the OTCQX under the symbol "VXRT" on July 8, 2025. Nov 13, 2025 · Vaxart (NASDAQ:VXRT) announced the adjournment of its 2025 special meeting of stockholders to September 19, 2025. (VXRT) stock, with a description, list of executives, contact details and other key facts. Find the latest Revenue & EPS data for Vaxart, Inc Common Stock (VXRT) at Nasdaq. May 12, 2025 · Vaxart (VXRT, Financial) has outlined its plan to conduct a reverse stock split at the upcoming Annual Meeting on Wednesday, May 21, 2025, as a strategic move to comply with Nasdaq's listing requirements. 24, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral Aug 29, 2025 · Vaxart (NASDAQ:VXRT), a clinical-stage biotech company developing oral recombinant pill vaccines, has received an extension from the Nasdaq Hearings Panel to regain compliance with the minimum bid price requirement. (Nasdaq: VXRT) today announced that an independent DSMB, which conducted a planned review of the 30-day safety data from May 5, 2025 · SOUTH SAN FRANCISCO, Calif. Vaxart Stock Performance Oct 7, 2021 · Vaxart, Inc. 4. (Nasdaq: VXRT) today issued the following letter to its stockholders from its President & Chief Executive Officer, Steven Lo. 35. (VXRT) announced late Monday that an independent Data Safety Monitoring Board or DSMB, which conducted a planned review of the 30-day safety data from a sentinel cohort of 4 days ago · View VAXART, INC VXRT investment & stock information. May 16, 2025 · Friday, VXRT closed at $0. (VXRT) came out with a quarterly loss of $0. Operator: Greetings, and Nov 17, 2025 · VXRT | Complete Vaxart Inc. 30 in pre-market hours Tuesday, giving back some of what it gained yesterday. Stay up-to-date on Vaxart, Inc Common Stock (VXRT) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. Jun 27, 2024 · Vaxart Inc's oral vaccines show promise for COVID-19, norovirus, and influenza but face financial challenges. , May 05, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT) at Nasdaq. Significant investment activity has been observed, with hedge funds such as Raymond James Financial and Invesco significantly increasing their holdings in Vaxart. (NASDAQ:VXRT) Suggests It's 26% Undervalued May 28, 2025 · Vaxart (VXRT) has provided detailed responses to stockholder questions ahead of its June 2, 2025 Annual Meeting, focusing on the crucial reverse stock split proposal. Oct 10, 2025 · Complete Vaxart Inc. 99% gain, and is trading at $0. Jul 5, 2024 · Biopharmaceutical company Vaxart, Inc. This put 6. 7 million underlying shares, working out to a Feb 26, 2024 · VAXART, INC. 22% and +1,206. 00, which poses a delisting risk for the company. (NASDAQ:VXRT) shares have recently dropped below their 200-day moving average of $0. to Report Q2, 2024 Results on Aug 08, 2024 Vaxart Receives Written Notice from Nasdaq Due to Non-Compliance with the Minimum Bid Price Requirement Set Forth in Nasdaq Listing Rule 5550 (a) (2) for Continued Listing on the Nasdaq Capital Market An Intrinsic Calculation For Vaxart, Inc. 4 days ago · See the latest Vaxart Inc stock price (VXRT:PINX), related news, valuation, dividends and more to help you make your investing decisions. (NASDAQ:VXRT - Get Free Report)'s share price passed below its 200-day moving average during trading on Thursday . Aug 13, 2025 · VAXART (VXRT) delivered earnings and revenue surprises of +22. 2 regarding a Reverse Stock Split, which aims to regain Nasdaq compliance for May 16, 2025 · SOUTH SAN FRANCISCO, Calif. , June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. 's (NASDAQ:VXRT) business as it appears the company may be on the cusp of a considerable accomplishment. 00. Sean Tucker urges stockholders to vote for a reverse stock split proposal to maintain Nasdaq compliance. 35M to 14. Jul 2, 2025 · Vaxart’s securities will remain suspended unless the panel decides to reinstate trading on Nasdaq. View the most recent data and latest information on option chains for Vaxart Inc. VXRT recently announced that it has started recruiting subjects for its phase II study evaluating its oral vaccine tablet for COVID-19. Pacific Time. Jun 11, 2025 · Vaxart (NASDAQ:VXRT) stock jumped 37. 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. 04, expectations were $-0. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral Vaxart, Inc Common Stock (VXRT) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. 14 BIOLASE Sep 14, 2021 · We feel now is a pretty good time to analyse Vaxart, Inc. (NASDAQ: VXRT), a biotech firm specializing in the development of vaccines with a market capitalization of $162 million, has been directed to halt work on a significant government Oct 9, 2024 · Vaxart Inc (VXRT) reports significant revenue growth and secures substantial funding, while navigating regulatory challenges and advancing its vaccine programs. The letter outlines key benefits of a Nasdaq listing, including broader investor access, enhanced visibility, and improved financial Oct 1, 2021 · And Vaxart Inc (Symbol: VXRT) options are showing a volume of 16,558 contracts thus far today. View the latest Vaxart Inc. , a clinical-stage Vaxart stock quote and VXRT charts. Feb 1, 2022 · Investors in Vaxart Inc (Symbol: VXRT) saw new options begin trading this week, for the February 18th expiration. (VXRT) with press releases and corporate news to help you in your trading and investing decisions. com Business News Mar 24, 2025 · Each trading day, Nasdaq publishes a list of Nasdaq issues that are pending suspension or delisting. (VXRT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. The company received a delisting notice from Nasdaq and has requested a hearing before the Nasdaq Hearings Panel, with its stock currently suspended from Nasdaq trading. Dear Vaxart, Inc. Mar 11, 2025 · (RTTNews) - Vaxart, Inc. 36 and a 200-day May 16, 2025 · SOUTH SAN FRANCISCO, Calif. Jun 14, 2024 · Stay up-to-date on Vaxart, Inc Common Stock (VXRT) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq. By May 5, 2025 · Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting as Recommended by Leading Independent Proxy Advisory Firms SOUTH SAN FRANCISCO, Calif. 40, trading as low as $0. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral Jun 11, 2025 · $VXRT stock has now risen 30% today, according to our price data from Polygon. (NASDAQ:VXRT) Q3 2025 Earnings Call Transcript November 13, 2025 Vaxart, Inc. Oct 20, 2025 · Get the latest insights on Vaxart Inc. Find the latest historical data for Vaxart, Inc Common Stock (VXRT) at Nasdaq. CEO Steven Lo emphasized the company Get real-time Vaxart Inc (VXRT) stock price, news, financials, community insights, and trading ideas. Do the numbers hold clues to what lies ahead for the stock? Vaxart, Inc Common Stock (VXRT) Historical Closing Prices - View free historical Nasdaq official closing price data at Nasdaq. Stay ahead with Nasdaq. Stay Informed on VXRT's Latest Pre Market Trades. An issue will appear on this list the first trading day after the issuer provides Nasdaq with Feb 24, 2025 · Vaxart, Inc. Find the latest analyst research, reports, and ratings for Vaxart, Inc Common Stock (VXRT) at Nasdaq. 35, with a volume of 2,480,363 shares. Analyst Price Forecast Suggests 765. Find the latest SEC Filings data for Vaxart, Inc Common Stock (VXRT) including 10-K and 10-Q forms at Nasdaq. 41, with a volume of 1,040,245 shares changing Mar 20, 2025 · VAXART (VXRT) delivered earnings and revenue surprises of 50% and 51. Jun 13, 2025 · SOUTH SAN FRANCISCO, Calif. These figures are adjusted Vaxart, Inc. The company must meet three critical conditions: obtain stockholder approval for a reverse stock split by September 5, 2025, complete the reverse split by October 6, 2025, and Jun 20, 2025 · Vaxart, Inc. Vaxart shares last traded at $0. Short interest in Vaxart Inc (NASDAQ:VXRT) increased during the last reporting period, rising from 14. View real-time stock prices and stock quotes for a full financial overview. Case in point: Since the turn of the year Vaxart (VXRT) stock has shot up by a sky scraping 680%, on the back of its Jul 29, 2025 · Vaxart, Inc. The company will hold a Special Meeting of Stockholders on September 5, 2025, to vote on a reverse split ratio between 1-for-5 and 1-for-20. 18% Upside May 21, 2025 · Vaxart (NASDAQ: VXRT) has announced the adjournment of its 2025 annual stockholders meeting to June 2, 2025 at 8:30 a. The company expects its common stock to begin trading on the over-the-counter market under the 2 days ago · Vaxart, Inc. Discover real-time Vaxart Inc. Every day the Zacks Equity Research analysts discuss the latest news . ET). Jun 11, 2025 · Vaxart's (NASDAQ:VXRT) shares rose following the positive results from an early-stage trial of its new oral pill vaccine for norovirus, a more advanced version compared to its first-generation 3 days ago · Stock forecasts and analyst price target predictions for Vaxart, Inc. Get the latest VAXART, INC VXRT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. (VXRT) announced on Tuesday that it has initiated a Phase 1, open-label, dose-ranging clinical trial for its second-generation oral norovirus vaccine. Oct 31, 2024 · One great example is Vaxart, Inc. m. May 14, 2025 · Vaxart Inc (VXRT) reports significant revenue growth and clinical advancements, despite facing operational hurdles and NASDAQ listing risks. beats earnings expectations. The company is particularly focused on gaining stockholder approval for Proposal No. (Nasdaq: VXRT) today addresses frequently asked stockholder questions regarding a reverse stock split proposal at the Find the latest on short interest, settlement dates, average share volume, and days to cover for Vaxart Inc. S. (Nasdaq: VXRT) today announced that it has filed a supplement to its proxy statement for its Annual Meeting. M. 97% on the Nasdaq Capital Market. Jul 8, 2025 · OTC Markets Group (OTCQX: OTCM) announced that Vaxart (OTCQX: VXRT), a clinical-stage biotechnology company, has qualified to trade on the OTCQX® Best Market. (VXRT) is down more than 6% at $7. (SOUN) is up over 117% at $14. Several equities research May 28, 2025 · --Vaxart, Inc. 5% The company has a 50-day moving average price of $0. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. Find the latest Vaxart, Inc. Jul 24, 2025 · SOUTH SAN FRANCISCO, Calif. , May 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. Aug 15, 2025 · Vaxart, Inc. 51% of the company's publicly available shares short. Get Vaxart Inc (VXRT:OTCQX) real-time stock quotes, news, price and financial information from CNBC. (NASDAQ: VXRT) Q2 2025 Earnings Call Transcript August 13, 2025 Vaxart, Inc. 9% premarket after the company reported positiveearly-stage data for its second-generation oral norovirus vaccine pill, with antibody responses up 141% against Nov 10, 2025 · When is Vaxart's next earnings announcement? View the latest VXRT earnings date, analysts forecasts, earnings history, and conference call transcripts. That number of contracts represents approximately 1. (NASDAQ:VXRT) Q2 2025 Earnings Call Transcript August 13, 2025 Vaxart, Inc. 07. 09. stock news by MarketWatch. In the Green SoundHound AI, Inc. , June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. 34, with a volume of 534,835 shares changing hands. (VXRT) is a Great Momentum Stock: Should You Buy? February 26, 2024 — 12:00 pm EST Written by Zacks Equity Research for Zacks -> Jul 24, 2025 · Vaxart (OTCQX: VXRT), a clinical-stage biotech company developing oral recombinant pill vaccines, has filed a preliminary proxy statement proposing a reverse stock split to regain Nasdaq compliance. In spite of the firm bounce in price, Vaxart may still look like a strong buying opportunity at Oct 10, 2025 · Vaxart, Inc. Key points include: the Board's commitment to a maximum 1-for-20 reverse split ratio (reduced from 1-for-50 Nov 7, 2025 · Company profile for Vaxart, Inc. Vaxart Stock Down 2. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 13% in the last twelve months. Vaxart (VXRT) stock price, charts, trades & the US's most popular discussion forums. Aug 7, 2025 · Vaxart, Inc. (Nasdaq: VXRT) today announced that it will present research featuring its COVID-19 and norovirus oral pill vaccine May 14, 2025 · Vaxart (NASDAQ: VXRT) shares rose in post-market trading on Wednesday after the company announced the publication of complete data from a Phase 2 trial for its oral pill norovirus vaccine May 12, 2025 · SOUTH SAN FRANCISCO, Calif. This comes as the company clarifies its $40 million capital raise, which extended its cash runway despite a large but cost-reimbursable Project NextGen award Nov 30, 2020 · For Immediate ReleaseChicago, IL – November 30, 2020 – Zacks. Learn why top analysts are making this stock forecast for Vaxart at MarketBeat. (NASDAQ:VXRT) which saw its share price drive 127% higher over five years. (VXRT) stock price, news, historical charts, analyst ratings and financial information from WSJ. (NASDAQ:VXRT - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Monday . capital markets while Jun 13, 2025 · SOUTH SAN FRANCISCO, Calif. Operator: Greetings, and May 28, 2025 · Vaxart is pushing for a reverse stock split to maintain its Nasdaq listing by the June 30 deadline, revising the maximum split ratio to 1-for-20 based on investor feedback and committing to proportionally reduce authorized shares. The stock has a two hundred day moving average of $0. Vaxart Inc. May 16, 2025 · Vaxart (VXRT) has announced important amendments to its proxy statement for the upcoming Annual Meeting. 05 in pre-market trading. Oct 1, 2021 · And Vaxart Inc (Symbol: VXRT) options are showing a volume of 16,558 contracts thus far today. Do the numbers hold clues to what lies ahead for the stock? Jul 11, 2025 · Vaxart, Inc. Jun 10, 2025 · Vaxart will release Phase I trial data for its norovirus vaccine on June 11, 2025, followed by a management conference call. The proposal aims to facilitate relisting on Nasdaq after the company's recent delisting. , Oct. Nov 15, 2025 · Vaxart, Inc. 50 and traded as low as $0. May 12, 2025 · SOUTH SAN FRANCISCO, Calif. Following trading suspension due to non-compliance with Sep 15, 2020 · In the Red 1. Quiver AI Summary Vaxart, Inc. (Nasdaq: VXRT) today addresses frequently asked stockholder questions regarding a reverse stock split proposal at the May 16, 2025 · SOUTH SAN FRANCISCO, Calif. Discover why technical analysis matters Oct 25, 2025 · Vaxart, Inc. These changes come as VXRT has a High Technical Rating by Nasdaq Dorsey Wright. 5051, marking an 18. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral May 5, 2025 · SOUTH SAN FRANCISCO, Calif. Operator: Greetings, and Sep 14, 2021 · We feel now is a pretty good time to analyse Vaxart, Inc. Jul 8, 2025 · Vaxart (OTCQX: VXRT), a clinical-stage biotechnology company developing oral recombinant pill vaccines, announced its transition to trading on the OTCQX Best Market effective July 8, 2025. May 12, 2025 · Vaxart urges stockholders to support a reverse stock split proposal to maintain Nasdaq compliance and avoid delisting. com announces the list of stocks featured in the Analyst Blog. 37, with a volume of 438,322 shares. Find annual and quearterly earnings data for Vaxart Inc. Jul 8, 2025 · SOUTH SAN FRANCISCO, Calif. Stay Informed on VXRT's Latest Trades, Real-Time Updates, Trade Volume, and Price Movements. , July 24, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. The company faces a June 30, 2025 Nasdaq compliance deadline and needs stockholder approval to maintain its listing. 3626, with a volume of 406,853 shares trading hands. 16 per share a year ago. 30. 10 A. View historical data in a monthly, bi-annual, or yearly format. Operator: Greetings, and Oct 24, 2024 · SOUTH SAN FRANCISCO, Calif. 53 and traded as low as $0. Nov 14, 2025 · Shares of Vaxart, Inc. 10 by $0. yfsun jnvwv aaeofj xdwonb tus qbfywmp djdak meyit kejk sqq siy qldmnehs jfyo vfei rovkt